Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $253.94 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aerie Pharmaceuticals, Inc. | $93.66 | 1 | $0 (2021) |
| Bioventus LLC | $49.00 | 1 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $28.93 | 1 | $0 (2024) |
| Mylan Specialty L.P. | $25.93 | 1 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.86 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $18.03 | 1 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $16.53 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $103.86 | 3 | Bioventus LLC ($49.00) |
| 2021 | $93.66 | 1 | Aerie Pharmaceuticals, Inc. ($93.66) |
| 2019 | $38.39 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($21.86) |
| 2018 | $18.03 | 1 | E.R. Squibb & Sons, L.L.C. ($18.03) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | Bioventus LLC | GELSYN-3 (Device) | Food and Beverage | In-kind items and services | $49.00 | General |
| Category: DEVICES | ||||||
| 03/08/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/08/2021 | Aerie Pharmaceuticals, Inc. | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $93.66 | General |
| Category: Glaucoma | ||||||
| 06/05/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.53 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/06/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.03 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 60 | 67 | $28,010 | $6,579 |
| 2022 | 2 | 35 | 44 | $15,016 | $3,789 |
| 2021 | 4 | 262 | 269 | $36,939 | $14,247 |
| 2020 | 4 | 137 | 138 | $41,392 | $12,778 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $15,950 | $3,270 | 20.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 20 | $7,000 | $1,912 | 27.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 22 | $5,060 | $1,398 | 27.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $7,656 | $1,944 | 25.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 32 | $7,360 | $1,845 | 25.1% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 76 | 77 | $14,063 | $5,569 | 39.6% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 91 | 97 | $8,528 | $3,504 | 41.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 66 | 66 | $9,373 | $3,275 | 34.9% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 13 | 13 | $3,568 | $1,336 | 37.5% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2021 | 16 | 16 | $1,407 | $562.46 | 40.0% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 86 | 87 | $14,464 | $4,973 | 34.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 26 | 26 | $16,093 | $4,455 | 27.7% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 11 | 11 | $6,246 | $1,735 | 27.8% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2020 | 14 | 14 | $4,589 | $1,615 | 35.2% |
About Lydia Zhang
Lydia Zhang is a Internal Medicine healthcare provider based in Newport, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235243346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lydia Zhang has received a total of $253.94 in payments from pharmaceutical and medical device companies, with $103.86 received in 2024. These payments were reported across 7 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($253.94).
As a Medicare-enrolled provider, Zhang has provided services to 494 Medicare beneficiaries, totaling 518 services with total Medicare billing of $37,394. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Newport, RI
- Active Since 08/18/2006
- Last Updated 12/05/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1235243346
Products in Payments
- rhopressa (Drug) $93.66
- GELSYN-3 (Device) $49.00
- UPTRAVI (Drug) $28.93
- YUPELRI (Drug) $25.93
- XIFAXAN (Drug) $21.86
- ELIQUIS (Drug) $18.03
- LifeVest (Device) $16.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newport
Candi Overholt, Md, MD
Internal Medicine — Payments: $18,838
Mr. Anton Daniel, Md, MD
Internal Medicine — Payments: $18,405
Niva Khan, M.d, M.D
Internal Medicine — Payments: $6,286
Vijoydeep Tanjore Venkoba Rao, Md, MD
Internal Medicine — Payments: $5,723
Dr. Adrian Velasquez, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $5,261
Abby Lauer, Md, MD
Internal Medicine — Payments: $3,626